Om

Proacta S.A. is a Polish technology company specializing in software development, bioinformatics, and artificial intelligence-based healthcare solutions. The company focuses on building medical and analytical platforms that support laboratory result interpretation, patient monitoring, and the use of medical and genetic data in clinical workflows. Its product portfolio includes solutions for digital diagnostics, oncology support, and health-data management, alongside custom IT services such as web and mobile applications, AI/ML development, cloud services, and system integration. Proacta also works with public institutions and private-sector clients, delivering dedicated technology projects tailored to specific operational needs. Based in Warsaw, Proacta S.A. plays a role in the intersection of healthcare, data science, and enterprise software within the Polish technology market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PROACTA MED ENDAVU: Køb PROACTA ($WS3) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i PROACTA, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.